{"id":"https://openalex.org/W2465233115","doi":null,"title":"Comparison of Panitumumab Plus Irinotecan and Cetuximab Plus Irinotecan for KRAS Wild-type Metastatic Colorectal Cancer.","display_name":"Comparison of Panitumumab Plus Irinotecan and Cetuximab Plus Irinotecan for KRAS Wild-type Metastatic Colorectal Cancer.","alternate_titles":[],"publication_year":2016,"publication_date":"2016-07-01","ids":{"openalex":"https://openalex.org/W2465233115","mag":"2465233115","pmid":"https://pubmed.ncbi.nlm.nih.gov/27354619"},"language":"en","primary_location":{"id":"pmid:27354619","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27354619","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Comparative Study"},"parent_works":[],"lineage":["https://openalex.org/W2465233115"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077816256","display_name":"Toshifumi Yamaguchi","orcid":"https://orcid.org/0000-0003-1399-1918","observed_orcids":["https://orcid.org/0000-0003-1399-1918"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Toshifumi Yamaguchi","raw_affiliation_strings":["Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067881155","display_name":"Satoru Iwasa","orcid":"https://orcid.org/0000-0003-3863-9582","observed_orcids":["https://orcid.org/0000-0003-3863-9582"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Satoru Iwasa","raw_affiliation_strings":["Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan siwasa@ncc.go.jp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan siwasa@ncc.go.jp","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026733873","display_name":"Kengo Nagashima","orcid":"https://orcid.org/0000-0003-4529-9045","observed_orcids":["https://orcid.org/0000-0003-4529-9045"]},"institutions":[{"id":"https://openalex.org/I4210099339","display_name":"Chiba University Hospital","ror":"https://ror.org/0126xah18","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210099339"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kengo Nagashima","raw_affiliation_strings":["Chiba University Hospital Clinical Research Center, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chiba University Hospital Clinical Research Center, Chiba, Japan","institution_ids":["https://openalex.org/I4210099339"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090868347","display_name":"Nobuaki Ikezawa","orcid":"https://orcid.org/0000-0001-9850-241X","observed_orcids":["https://orcid.org/0000-0001-9850-241X"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nobuaki Ikezawa","raw_affiliation_strings":["Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112010683","display_name":"Tetsuya Hamaguchi","orcid":"https://orcid.org/0009-0001-0798-1396","observed_orcids":["https://orcid.org/0009-0001-0798-1396"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tetsuya Hamaguchi","raw_affiliation_strings":["Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008535163","display_name":"Hirokazu Shoji","orcid":"https://orcid.org/0000-0002-8922-5227","observed_orcids":["https://orcid.org/0000-0002-8922-5227"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hirokazu Shoji","raw_affiliation_strings":["Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058567838","display_name":"Yoshitaka Honma","orcid":"https://orcid.org/0000-0002-4209-4493","observed_orcids":["https://orcid.org/0000-0002-4209-4493"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yoshitaka Honma","raw_affiliation_strings":["Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023430800","display_name":"Atsuo Takashima","orcid":"https://orcid.org/0000-0002-8456-1248","observed_orcids":["https://orcid.org/0000-0002-8456-1248"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Atsuo Takashima","raw_affiliation_strings":["Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059834800","display_name":"Natsuko Tsuda Okita","orcid":"https://orcid.org/0000-0002-3990-5048","observed_orcids":["https://orcid.org/0000-0002-3990-5048"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Natsuko Okita","raw_affiliation_strings":["Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100547218","display_name":"Ken Kato","orcid":"https://orcid.org/0009-0006-4866-545X","observed_orcids":["https://orcid.org/0009-0006-4866-545X"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ken Kato","raw_affiliation_strings":["Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079864042","display_name":"Yasuhide Yamada","orcid":"https://orcid.org/0000-0003-0692-8419","observed_orcids":["https://orcid.org/0000-0003-0692-8419"]},"institutions":[{"id":"https://openalex.org/I4405285273","display_name":"National Cancer Center Hospital","ror":"https://ror.org/053hhpd64","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405285273"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yasuhide Yamada","raw_affiliation_strings":["Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gastrointestinal Oncology Division, National Cancer Center Hospital, Tokyo, Japan","institution_ids":["https://openalex.org/I4405285273"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101787797","display_name":"Yasuhiro Shimada","orcid":"https://orcid.org/0000-0003-1385-696X","observed_orcids":["https://orcid.org/0000-0003-1385-696X"]},"institutions":[{"id":"https://openalex.org/I4405256591","display_name":"Kochi Health Sciences Center","ror":"https://ror.org/04b3jbx04","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405256591"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yasuhiro Shimada","raw_affiliation_strings":["Department of Medical Oncology, Kochi Health Sciences Center, Kochi, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Kochi Health Sciences Center, Kochi, Japan","institution_ids":["https://openalex.org/I4405256591"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7104,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.70043191,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"36","issue":"7","first_page":"3531","last_page":"3536"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/panitumumab","display_name":"panitumumab","score":0.9879999756813049},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":1.0},{"id":"https://openalex.org/keywords/kras-wild-type","display_name":"KRAS wild-type","score":0.8500000238418579},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":1.0},{"id":"https://openalex.org/keywords/anti-egfr-therapy","display_name":"anti-EGFR therapy","score":0.7490000128746033},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.6420000195503235},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.625},{"id":"https://openalex.org/keywords/fluoropyrimidine","display_name":"fluoropyrimidine","score":0.9599999785423279},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8299999833106995},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9359999895095825},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.4830000102519989}],"concepts":[{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.9710537195205688},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.9707280993461609},{"id":"https://openalex.org/C2778332735","wikidata":"https://www.wikidata.org/wiki/Q417775","display_name":"Panitumumab","level":5,"score":0.9547024965286255},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.8134509325027466},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7773632407188416},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.7217267155647278},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6497945785522461},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.6085594892501831},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6080812215805054},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2864260673522949}],"mesh":[{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077150","descriptor_name":"Oxaliplatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077544","descriptor_name":"Panitumumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016283","descriptor_name":"Proto-Oncogene Proteins p21(ras)","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:27354619","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27354619","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Comparative Study"},{"id":"mag:2465233115","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27354619","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W2565752417"],"related_works":["https://openalex.org/W2590480900","https://openalex.org/W3030160958","https://openalex.org/W3035430680","https://openalex.org/W2170251966","https://openalex.org/W2165225928","https://openalex.org/W1914703704","https://openalex.org/W4406229279","https://openalex.org/W3116599757","https://openalex.org/W1799531120","https://openalex.org/W2621192640"],"abstract_inverted_index":{"BACKGROUND/AIM:":[0],"Panitumumab":[1,164],"and":[2,46,73,79,102,126,140,146,158,169],"cetuximab":[3,90,103,130,147,179],"are":[4],"known":[5],"to":[6,87,176],"be":[7],"effective":[8],"treatments":[9],"for":[10,64],"KRAS":[11,38,65],"wild-type":[12,39,66],"metastatic":[13],"colorectal":[14],"cancer":[15],"(mCRC).":[16],"However,":[17],"it":[18],"remains":[19],"unclear":[20],"which":[21],"of":[22,81,89,96,174,178],"these":[23],"two":[24],"biologic":[25],"agents":[26],"confers":[27],"the":[28,97,115,121,129,144],"greatest":[29],"benefit":[30],"when":[31],"combined":[32],"with":[33,37,43,62,70,112,156,161],"irinotecan":[34,74,84,100,105,124,132,166],"in":[35,60,120,128,143],"patients":[36,54,111],"mCRC":[40,67],"previously":[41,68],"treated":[42,69],"fluoropyrimidine,":[44,71],"oxaliplatin":[45,72],"irinotecan.":[47,92,181],"PATIENTS":[48],"AND":[49],"METHODS:":[50],"Data,":[51],"from":[52],"139":[53],"who":[55],"received":[56],"panitumumab":[57,82,98,122,145,157],"or":[58],"cetuximab,":[59],"combination":[61],"irinotecan,":[63],"were":[75,108],"analyzed.":[76],"The":[77],"efficacy":[78,175],"safety":[80],"plus":[83,91,99,104,123,131,165,180],"was":[85,118,138,153,167],"compared":[86],"that":[88,177],"RESULTS:":[93],"Baseline":[94],"characteristics":[95],"(n=42)":[101],"(n=97)":[106],"groups":[107],"similar.":[109],"Among":[110],"measurable":[113],"lesions,":[114],"response":[116],"rate":[117],"34%":[119],"group":[125],"20%":[127],"group.":[133],"Median":[134,150],"progression-free":[135],"survival":[136,152],"(PFS)":[137],"4.3":[139],"5.7":[141],"months":[142,155,160],"groups,":[148],"respectively.":[149],"overall":[151],"13.6":[154],"11.2":[159],"cetuximab.":[162],"CONCLUSION:":[163],"well-tolerated":[168],"displayed":[170],"a":[171],"similar":[172],"level":[173]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2465233115","counts_by_year":[{"year":2022,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-07-22T00:00:00"}
